ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in ImageneBio, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- −4 vs. Q3 2024
- Shares held
- 31.7M
- +3.30M (+11.6%) vs. Q3 2024
- Total value
- $52.0M
- +$2.86M (+5.8%) vs. Q3 2024
- New holders
- 7
- 9 more added
- Sold out
- 11
- 20 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $8.23M | 1.00% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 4,091,118 | $6.71M | 1.59% | 00.0% | Unchanged |
| BVF Inc | 4,006,564 | $6.57M | 0.22% | −762,600−16.0% | Reduced |
| BML Capital Management, LLC | 3,585,866 | $5.88M | 3.65% | +2,862,578+395.8% | Added |
| OrbiMed Advisors LLC | 3,539,358 | $5.80M | 0.12% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 2,249,123 | $3.69M | 2.39% | 00.0% | Unchanged |
| Gilead Sciences, Inc. | 2,008,338 | $3.29M | 0.21% | +2,008,338 | New |
| Vanguard Group Inc | 1,384,664 | $2.27M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 800,000 | $1.31M | 0.00% | −187,900−19.0% | Reduced |
| NEA Management Company, LLC | 600,063 | $984.1K | 0.06% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 507,868 | $832.9K | 0.83% | +507,868 | New |
| Sofinnova Investments, Inc. | 382,616 | $627.5K | 0.05% | 00.0% | Unchanged |
| BlackRock, Inc. | 352,136 | $577.5K | 0.00% | −400.0% | Reduced |
| Renaissance Technologies LLC | 330,200 | $541.5K | 0.00% | −70,400−17.6% | Reduced |
| Geode Capital Management, LLC | 327,962 | $538.0K | 0.00% | +56,936+21.0% | Added |
| Jacobs Levy Equity Management, Inc | 327,410 | $537.0K | 0.00% | −61,338−15.8% | Reduced |
| Acadian Asset Management LLC | 288,368 | $471.0K | 0.00% | −37,345−11.5% | Reduced |
| Millennium Management LLC | 199,684 | $327.5K | 0.00% | −49,733−19.9% | Reduced |
| Barclays PLC | 195,311 | $320.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 157,400 | $258.1K | 0.00% | −44,700−22.1% | Reduced |
| JPMorgan Chase & Co | 155,741 | $255.4K | 0.00% | +154,892+18,244.1% | Added |
| Bridgeway Capital Management, LLC | 153,800 | $252.2K | 0.01% | −4,600−2.9% | Reduced |
| Two Sigma Investments, LP | 100,778 | $165.3K | 0.00% | −55,935−35.7% | Reduced |
| State Street Corp | 92,153 | $151.1K | 0.00% | +11,800+14.7% | Added |
| Deuterium Capital Management, LLC | 80,579 | $132.2K | 0.35% | 00.0% | Unchanged |
| Citadel Advisors LLC | 80,368 | $131.8K | 0.00% | −84,647−51.3% | Reduced |
| Marquette Asset Management, LLC | 72,890 | $119.5K | 0.02% | 00.0% | Unchanged |
| JBF Capital, Inc. | 72,647 | $119.1K | 0.02% | 00.0% | Unchanged |
| UBS Group AG | 71,856 | $117.8K | 0.00% | +71,784+99,700.0% | Added |
| BBR Partners, LLC | 70,000 | $114.8K | 0.01% | −60,000−46.2% | Reduced |
| Northern Trust Corp | 57,565 | $94.4K | 0.00% | +9,456+19.7% | Added |
| Goldman Sachs Group Inc | 47,095 | $77.2K | 0.00% | −11,528−19.7% | Reduced |
| BNP Paribas Arbitrage, SA | 44,040 | $72.2K | 0.00% | +44,040 | New |
| Squarepoint Ops LLC | 43,640 | $71.6K | 0.00% | +43,640 | New |
| Dimensional Fund Advisors LP | 38,621 | $63.2K | 0.00% | 00.0% | Unchanged |
| Vazirani Asset Management LLC | 25,000 | $41.0K | 0.13% | −90,668−78.4% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 21,184 | $34.7K | 0.01% | −962−4.3% | Reduced |
| Engineers Gate Manager LP | 18,934 | $31.1K | 0.00% | +18,934 | New |
| Berkshire Asset Management LLC | 20,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 18,200 | $29.8K | 0.00% | −11,600−38.9% | Reduced |
| JustInvest LLC | 16,369 | $26.8K | 0.00% | −1,426−8.0% | Reduced |
| Morgan Stanley | 15,403 | $25.3K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 12,528 | $20.5K | 0.00% | +12,528 | New |
| Charles Schwab Investment Management Inc | 12,304 | $20.2K | 0.00% | +238+2.0% | Added |
| FMR LLC | 10,587 | $17.4K | 0.00% | −27,787−72.4% | Reduced |
| Tower Research Capital LLC (TRC) | 3,633 | $5.96K | 0.00% | +1,758+93.8% | Added |
| Advisor Group Holdings, Inc. | 1,503 | $2.46K | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 564 | $926 | 0.00% | −6,152−91.6% | Reduced |
| Bank of America Corp | 251 | $412 | 0.00% | +52+26.1% | Added |
| SRS Capital Advisors, Inc. | 235 | $386 | 0.00% | −64−21.4% | Reduced |
| Farther Finance Advisors, LLC | 108 | $177 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 99 | $162 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 3 | $5 | 0.00% | +3 | New |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −449,656−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −231,383−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −57,090−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −50,638−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −44,635−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −37,270−100.0% | Sold out |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −24,830−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −17,352−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,728−100.0% | Sold out |